EE200000018A - 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine - Google Patents
6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamineInfo
- Publication number
- EE200000018A EE200000018A EEP200000018A EEP200000018A EE200000018A EE 200000018 A EE200000018 A EE 200000018A EE P200000018 A EEP200000018 A EE P200000018A EE P200000018 A EEP200000018 A EE P200000018A EE 200000018 A EE200000018 A EE 200000018A
- Authority
- EE
- Estonia
- Prior art keywords
- ylpyridines
- pyrrolidin
- preparation
- therapeutic use
- therapeutic
- Prior art date
Links
- NDCZQFDBSPOUDF-UHFFFAOYSA-N 2-pyrrolidin-2-ylpyridine Chemical class C1CCNC1C1=CC=CC=N1 NDCZQFDBSPOUDF-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9708706A FR2765874B1 (fr) | 1997-07-09 | 1997-07-09 | Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique |
| PCT/FR1998/001446 WO1999002517A1 (fr) | 1997-07-09 | 1998-07-07 | Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200000018A true EE200000018A (et) | 2000-08-15 |
Family
ID=9509040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000018A EE200000018A (et) | 1997-07-09 | 1998-07-07 | 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6184229B1 (xx) |
| EP (1) | EP1000056A1 (xx) |
| JP (1) | JP2002508004A (xx) |
| KR (1) | KR20010021617A (xx) |
| CN (1) | CN1262680A (xx) |
| AR (1) | AR013192A1 (xx) |
| AU (1) | AU8544498A (xx) |
| BG (1) | BG104037A (xx) |
| BR (1) | BR9811672A (xx) |
| CA (1) | CA2295666A1 (xx) |
| CO (1) | CO4890850A1 (xx) |
| EE (1) | EE200000018A (xx) |
| FR (1) | FR2765874B1 (xx) |
| HU (1) | HUP0003856A2 (xx) |
| IL (1) | IL133536A0 (xx) |
| NO (1) | NO20000066L (xx) |
| PL (1) | PL338123A1 (xx) |
| SK (1) | SK212000A3 (xx) |
| TR (1) | TR200000057T2 (xx) |
| WO (1) | WO1999002517A1 (xx) |
| ZA (1) | ZA986047B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005126340A (ja) * | 2003-10-22 | 2005-05-19 | Kureha Chem Ind Co Ltd | 置換ピリドン類の製造法、その原料化合物及びその製造方法 |
| EP1802258A4 (en) | 2004-09-13 | 2015-09-23 | Chrono Therapeutics Inc | BIOSYNCHRONE TRANSDERMAL MEDICINES |
| ES2521494T3 (es) | 2007-04-02 | 2014-11-12 | Parkinson's Institute | Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos |
| JP2018511355A (ja) | 2015-01-28 | 2018-04-26 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 薬剤送達方法及びシステム |
| JP2020503950A (ja) | 2017-01-06 | 2020-02-06 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 経皮薬剤送達の装置及び方法 |
| US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| CA3119992A1 (en) | 2018-11-16 | 2020-05-22 | Morningside Venture Investments Limited | Thermally regulated transdermal drug delivery system |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5227391A (en) * | 1992-04-10 | 1993-07-13 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| US5232933A (en) * | 1992-05-21 | 1993-08-03 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
-
1997
- 1997-07-09 FR FR9708706A patent/FR2765874B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-07 IL IL13353698A patent/IL133536A0/xx unknown
- 1998-07-07 SK SK21-2000A patent/SK212000A3/sk unknown
- 1998-07-07 BR BR9811672-0A patent/BR9811672A/pt not_active IP Right Cessation
- 1998-07-07 CN CN98807003A patent/CN1262680A/zh active Pending
- 1998-07-07 US US09/462,352 patent/US6184229B1/en not_active Expired - Fee Related
- 1998-07-07 WO PCT/FR1998/001446 patent/WO1999002517A1/fr not_active Ceased
- 1998-07-07 EP EP98936453A patent/EP1000056A1/fr not_active Withdrawn
- 1998-07-07 HU HU0003856A patent/HUP0003856A2/hu unknown
- 1998-07-07 EE EEP200000018A patent/EE200000018A/xx unknown
- 1998-07-07 PL PL98338123A patent/PL338123A1/xx unknown
- 1998-07-07 CA CA002295666A patent/CA2295666A1/en not_active Abandoned
- 1998-07-07 JP JP50824799A patent/JP2002508004A/ja active Pending
- 1998-07-07 KR KR1020007000175A patent/KR20010021617A/ko not_active Withdrawn
- 1998-07-07 AU AU85444/98A patent/AU8544498A/en not_active Abandoned
- 1998-07-07 TR TR2000/00057T patent/TR200000057T2/xx unknown
- 1998-07-08 AR ARP980103305A patent/AR013192A1/es not_active Application Discontinuation
- 1998-07-08 ZA ZA986047A patent/ZA986047B/xx unknown
- 1998-07-08 CO CO98038696A patent/CO4890850A1/es unknown
-
1999
- 1999-12-22 BG BG104037A patent/BG104037A/xx unknown
-
2000
- 2000-01-06 NO NO20000066A patent/NO20000066L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2765874A1 (fr) | 1999-01-15 |
| US6184229B1 (en) | 2001-02-06 |
| HUP0003856A2 (hu) | 2001-10-28 |
| NO20000066D0 (no) | 2000-01-06 |
| IL133536A0 (en) | 2001-04-30 |
| FR2765874B1 (fr) | 1999-08-13 |
| CN1262680A (zh) | 2000-08-09 |
| BR9811672A (pt) | 2000-09-19 |
| CA2295666A1 (en) | 1999-01-21 |
| NO20000066L (no) | 2000-03-09 |
| ZA986047B (en) | 1999-02-01 |
| JP2002508004A (ja) | 2002-03-12 |
| SK212000A3 (en) | 2000-06-12 |
| PL338123A1 (en) | 2000-09-25 |
| AU8544498A (en) | 1999-02-08 |
| WO1999002517A1 (fr) | 1999-01-21 |
| TR200000057T2 (tr) | 2000-08-21 |
| AR013192A1 (es) | 2000-12-13 |
| CO4890850A1 (es) | 2000-02-28 |
| EP1000056A1 (fr) | 2000-05-17 |
| KR20010021617A (ko) | 2001-03-15 |
| BG104037A (en) | 2001-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI955235A7 (fi) | Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö | |
| PT911340E (pt) | Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos | |
| FI964311L (fi) | Bifunktionaalinen proteiini, valmistus ja käyttö | |
| NL300295I1 (nl) | 3,3-Diarylpropylaminen, de toepassing en bereiding hiervan | |
| EE200000658A (et) | CD23 antikehad, nende derivaadid ja nende terapeutiline kasutamine | |
| ID24118A (id) | Terapi gabungan | |
| EE200000037A (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena | |
| EE200200160A (et) | 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid | |
| EE200000621A (et) | Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine | |
| EE200100470A (et) | Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| FI954763A7 (fi) | Oksiinijohdannaiset, niiden valmistus ja niiden terapeuttinen käyttö | |
| FI956298A0 (fi) | 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö | |
| FI970997A7 (fi) | Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö | |
| NO992676D0 (no) | 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse | |
| FI940425A7 (fi) | Modifioidut oligodeoksiribonukleotidit, niiden valmistus ja niiden terapeuttinen käyttö | |
| EE9800451A (et) | Uued imidasotriasolopürimidiinid, nende valmistamismeetod ja kasutamine ravimainetena | |
| EE200000207A (et) | 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| EE200000018A (et) | 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine | |
| FI970750L (fi) | Indoli-2,3-dioni-3-oksimijohdannaisia, niiden valmistus ja käyttö | |
| FI972965A7 (fi) | Uusia peptidejä, niiden valmistus ja käyttö | |
| FI956251A0 (fi) | 1-okso-2-(fenyylisulfonyyliamino)pentyylipiperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| FI971317A7 (fi) | Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö | |
| FI954141L (fi) | Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa | |
| FI964446L (fi) | Uusia tetrapeptidejä, niiden valmistus ja käyttö | |
| FI965172L (fi) | Uusia amido-kinoksaliinidioneja, niiden valmistus ja käyttö |